Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Invests In China Oncology Start-up BeiGene

May 02 2011

• By PharmAsia News

Related Content

PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter

Nov 20 2009

Regulatory Revisions, Cut Backs At Big Pharma, Provide Spark For China Innovation - BayHelix Annual Meeting

Apr 20 2011

Merck China CEO Michel Vounatsos And Emerging Markets R&D Senior VP RuiPing Dong On Provincial Management: An Interview With PharmAsia News

Apr 20 2011

ASLAN Completes Series A Funding For $12 Mn; Eyes More Financing Options With Spiraling Portfolio

Apr 27 2011

Is China A Black Swan For Big Pharma? (Part 2 of 2)

Apr 26 2011

Ascletis Raises $100MM To Deploy Its U.S.-China Hybrid Drug Development Model

Apr 06 2011

More from Archive

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window